RP Bio Inc. (KOSDAQ:314140)
6,400.00
0.00 (0.00%)
At close: Apr 20, 2026
RP Bio Revenue
In the year 2025, RP Bio had annual revenue of 136.22B KRW with 9.88% growth. RP Bio had revenue of 33.31B in the quarter ending December 31, 2025, with 6.43% growth.
Revenue
136.22B
Revenue Growth
+9.88%
P/S Ratio
0.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
55.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 136.22B | 12.25B | 9.88% |
| Dec 31, 2024 | 123.97B | -27.08B | -17.93% |
| Dec 31, 2023 | 151.05B | 12.94B | 9.37% |
| Dec 31, 2022 | 138.11B | 23.15B | 20.13% |
| Dec 31, 2021 | 114.96B | 17.04B | 17.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 201.20B |
| Jin Yang Pharmaceutical | 120.69B |
| Hwail Pharmaceutical | 107.87B |
| GeneBioTech Co. ,Ltd | 90.79B |
| Sinil Pharmaceutical | 80.56B |
| Korean Drug | 62.51B |
| Kyung Nam Pharm | 56.18B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |